Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000030.xml
Der Klinikarzt 2020; 49(07/08): 292-298
DOI: 10.1055/a-1220-4425
DOI: 10.1055/a-1220-4425
Schwerpunkt
Labordiagnostik bei SARS-CoV-2-Infektionen
Erregeridentifizierung, Antikörperdiagnostik und Beurteilung des KrankheitsverlaufsFurther Information
Publication History
Publication Date:
28 August 2020 (online)
ZUSAMMENFASSUNG
Die aktuelle COVID-19-Pandemie stellte auch die medizinischen Labore vor große Herausforderungen. Der prinzipiell sehr frühen Kenntnis des primär neuen Erregers und der prinzipiellen Möglichkeit des Nachweises des Virus stand oft eine zunächst unzureichende Verfügbarkeit an Reagenzien und Analysensystemen gegenüber, die aber relativ schnell verbessert werden konnten, sodass nun eine flächendeckende und schnelle Diagnostik dieses Erregers möglich ist. Neben der Erregeridentifizierung liefert die Labordiagnostik jedoch auch wichtige Hinweise bei der Beurteilung der Erkrankung bzw. der Abschätzung des weiteren Verlaufes. Die Wertigkeit einzelner Parameter bzw. Parameterkonstellationen wurde dabei teilweise erst im Verlauf der Pandemie deutlich bzw. ist auch noch in der Evaluierung.
-
Literatur
- 1 Wang LF, Anderson DE, Mackenzie JS. et al From Hendra to Wuhan: what has been learned in responding. Lancet 2020; 295: e33-e34
- 2 Phillips N, Mallapaty S, Cyranosk Di. How quickly does the Wuhan virus spread?. Nature 2020 https://www.nature.com/articles/d41586-020-00146-w In: Nature. 21. Januar 2020, doi:10.1038/d41586-020-00146-w
- 3 Gorbalenya AE, Baker SC, Baric RS. et al Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv 2020 https://doi.org/10.1101/2020.02.07.937862
- 4 Roujian L, Xiang Z, Juan L. et al Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395: 565-574
- 5 Kuhn JH, Jahrling PB. Clarification and guidance on the proper usage of virus and virus species names. Arch Virol 2010; 155: 445-453
- 6 Delmas B, Laude H. Assembly of Coronavirus Spike Protein Into Trimers and Its Role in Epitope Expression. J Virol 1990; 64: 5367-5375
- 7 Wrapp D, Wang N, Corbett KC. et al Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367: 1260-1263
- 8 Yan R, Zhang Y, Li Y. et al Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367: 1444-1448
- 9 Biological.com, Sino Spike Protein/S Protein. https://www.sinobiological.com/research/virus/hcov-spike-protein-overview abgerufen am 29.06.2020
- 10 Hoffmann M, Kleine-Weber H, Pöhlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Molrcular Cell 2020; 78: 1-6
- 11 Wu F, Zhao S, Yu B. Wuhan seafood market pneumonia virus isolate Wuhan-Hu-1, complete genome. NCBI 2020 https://www.ncbi.nlm.nih.gov/nuccore/MN908947
- 12 Nucleotide, NCBI Database txid2697049 (Severe acute respiratory syndrome coronavirus 2). Website Nucleotide des National Center for Biotechnology Information (NCBI) https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=2697049
- 13 Denison MR, Graham RL, Donaldson EF. et al Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biology 2011; 8: 270-279
- 14 Anfinrud P, Bax CE, Stadnytskyi V, Bax A. et al Could SARS-CoV-2 be transmitted via speech droplets?. MedRxiv 2020 doi: https://doi.org/10.1101/2020.04.02.20051177
- 15 Anfinrud P, Stadnytskyi V, Bax CE, Bax A. Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering. New Engl J Med 2020; 382: 2061-2063
- 16 van Doremalen N, Bushmaker T, Morris DH. et al Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New Engl J Med 2020; 382: 1564-1567
- 17 Stadnytskyia V, Baxb CE, Baxa A. et al The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. PNAS 2020; 117: 11875-11877
- 18 Fears AC, Klimstra WB, Duprex P. et al Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions. medRxiv 2020 Preprint 2020 Apr 18 https://doi.org/10.1101/2020.04.13.20063784
- 19 Bourouiba L. Turbulent Gas Clouds and Respiratory Pathogen Emissions Potential Implications for Reducing Transmission of COVID-19. JAMA 2020; 323: 1837-1838
- 20 van der Hoek L. Human coronaviruses: what do they cause?. Antivir Ther 2007; 12: 651-658
- 21 Rockx B, Kuiken T, Sander Herfst S. et al Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 2020; 368: 1012-1015
- 22 Hassanin A. Coronavirus Could Be a ‘Chimera’ of Two Different Viruses, Genome Analysis Suggests. Science alert 2020 https://www.sciencealert.com/genome-analysis-of-the-coronavirus-suggests-two-viruses-may-have-combined
- 23 Sae TH. coronavirus-covid-19-not-human-made-lab-genetic-analysis-nature. ScienceNews 2020 https://www.sciencenews.org/article/coronavirus-covid-19-not-human-made-lab-genetic-analysis-nature
- 24 Li X, Giorgi EE, Marichannegowda MH. et al Emergence of SARS-CoV-2 through recombination and strong purifying selection. Science Advances 2020 Preprint 2020 Mar 22, doi:10.1126/sciadv.abb9153
- 25 Andersen KG, Rambaut A, Lipkin I. et al The proximal origin of SARS-CoV-2. Nature Medicine 2020; 26: 450-455
- 26 Deslandes A, Berti V, Tandjaoui-Lambotte Y. et al SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents 2020; 55: 106006
- 27 Corman V, Bleicker T, Sebastian Brünink S. et al Diagnostic detection of Wuhan coronavirus 2019 by real-time RTPCR. https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 (abgerufen am 29.06.2020)
- 28 Carter LJ, Garner LV, Jeffrey Smoot JW. et al Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Cent Sci 2020; 6: 591-605
- 29 Nahapetyan K, Inbanathan F, Pereyaslov D. et al Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. WHO Interim guidance 2020 S. WHO/COVID-19/laboratory/2020.4
- 30 Bundesvereinigung, Kassenärztliche Einheitlicher Bewertungsmaßstab (EBM) Arztgruppen EBM Labormedizin. 2020 Stand 2/2020, erstellt am 05.06.2020
- 31 Broughton JP, Deng X, Yu G. et al CRISPR–Cas12-based detection of SARS-CoV-2. Nature Biotechnology 2020 https://doi.org/10.1038/s41587-020-0513-4
- 32 Wu Z, Jennifer M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-1242
- 33 Aylward B, Dong X, Eckmanns T. et al Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Organization, World Health 2020 https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
- 34 Huang C, Wang Y, Li X. et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506
- 35 Li H, Liu L, Zhang D. et al SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet 2020; 395: 1517-1520
- 36 Spinato G, Fabbris C, Polesel J. et al Alterations in Smell or Taste in Mildly Symptomatic OutpatientsWith SARS-CoV-2 Infection. JAMA 2020; 323: 2089-2090
- 37 Institut, Robert Koch SARS-CoV-2 Steckbrief zur Coronavirus-Krankheit-2019 (COVID-19),. Stand 26.05.2020. 2020,/ www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html#doc13776792bodyText5
- 38 van Kasteren PB, van der Veer B, van den Brink S. et al Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol 2020; 128: 104412
- 39 Wang D, Hu B, Hu C. et al Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia inWuhan, China. JAMA 2020; 323: 1061-1069
- 40 Koorak S, Hosseiny M, Myers L. et al Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know. J Am Coll Radiol 2020; 17: 447-451
- 41 Prevention, Korea Center of Disease Control & Findings from Investigation and Analysis of re-positive Cases. 2020 https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030&act=view&list_no=367267&nPage=8
- 42 Wu J, Liu X, Liu J. et al Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China. JAMA 2020; 5: e209759
- 43 Dreher M, Kersten A, Bickenbach J. et al Charakteristik von 50 hospitalisierten COVID-19-Patienten mit und ohne ARDS. Deutsches Ärzteblatt 2020; 117: 271-278
- 44 Shen C, Wang Z, Zhao F. et al Treatment of 5 Critically Ill Patients WithCOVID-19 With Convalescent Plasma. JAMA 2020; 323: 1582-1589
- 45 Wölfel R, Corman VM, Guggemos W. et al Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster. medRxiv https://doi.org/10.1101/2020.03.05.20030502
- 46 Wölfel R, Corman VM, Guggemos W. et al Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581: 465-469
- 47 Helms J, Kremer S, Merdji H. et al Neurologic Features in Severe SARS-CoV-2 Infection. New Engl J Med 2020; 382: 2268-2270
- 48 Li D, Jin M, Bao P. et al Clinical Characteristics and Results of Semen Tests Among Men. JAMA Netw Open 2020; 3: e208292
- 49 Groß R, Conzelmann C, Müller JA. et al Detection of SARS-CoV-2 in human breastmilk. Lancet 2020; 395: 1757-1758
- 50 WHO https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnancy-breastfeeding.html 2020
- 51 Streeck H, Schulte B, Kümmerer BM. et al Infection fatality rate of SARS-CoV-2 infection in a German. MEDRxiv 2020 S. Infection fatality rate of SARS-CoV-2 infection in a German https://doi.org/10.1101/2020.05.04.20090076
- 52 Bendavid E, Mulaney B, Sood N. et al COVID-19 Antibody Seroprevalence in Santa Clara County, California. medRxiv 2020 https://doi.org/10.1101/2020.04.14.20062463
- 53 Deeks JJ, Dinnes J, Takwoingi Y. et al Antibody tests for identification of current and past infection with SARS-CoV-2 (Review). Cochrane Database Syst Rev 2020; 6: CD013652
- 54 Steensels D, Oris E, Coninx L. et al Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. JAMA 2020; 324: 195-197
- 55 Long QX, Liu BT, Deng HJ. et al Antibody responses to SARS-CoV-2 in patients. Nature Medicine 2020; 26: 845-848
- 56 Padoana A, Sciacovellib L. Bassoa, et al. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with. Clinica Chimica Acta 2020; 507: 164-166
- 57 Sethuraman N, Stanleyraj S, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA 2020 2020 May 6. doi: 10.1001/jama.2020.8259. Online ahead of print
- 58 Ballini L, Djuric O, Venturelli F. et al Rapid collaborative Review on the current Role of Antibody Tests for novel Coronavirus SarsC0V-2 in the Management of the Pandemic. European Network for Health Technology Assessment 2020 Project ID: RCR OT 01, Version 1.2, 22 Juni 2020 https://eunethta.eu/wp-content/uploads/2020/05/project_plan_antibody-tests-for-COVID-19_12-05-2020_FINAL.pdf
- 59 Bundesvereinigung, Kassenärztliche Coronavirus: Informationen für Ärzte, Psychotherapeuten und Praxisteams. 2020 https://www.kbv.de/html/coronavirus.php (abgerufen am 26.06.2020)
- 60 Young BE, Xiang SW, Kalimuddin S al et. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA 2020; 323: 1488-1494
- 61 Wang D, Hu B, Hu C. Clinical Characteristics of 138 Hospitalized Patients Clinical Characteristics of 138 Hospitalized Patients. JAMA 2020; 323: 1061-1069
- 62 Guan W, Ni Z, Hu Y. et al Clinical Characteristics of Coronavirus Disease 2019 in China. New Engl J Med 2020; 382: 1708-1720
- 63 Lippi G, Plebanib M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clinica Chimica Acta 2020; 505: 190-191
- 64 Lu X, Zhang L, Du H. et al SARS-CoV-2 Infection in Children. New Engl J Med 2020; 282: 1663-1665
- 65 Henry BM, Lippia G, Plebania M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med 2020; 58: 1135-1138
- 66 Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020; 92: 1-4
- 67 Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S. et al Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology 2020 https://doi.org/10.1212/WNL.0000000000009619
- 68 Zhao H, Shen D, Zhou H. et al Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet/Neurology 2020; 19: 383-384
- 69 Toscano G, Palmerini F, Ravaglia S. et al Guillain–Barré Syndrome Associated with SARS-CoV-2. New Engl J Med 2020; 20: e00771
- 70 Jiang X, Coffee M, Bari A. et al Towards an Artificial Intelligence Framework for Data-Driven Prediction of Coronavirus Clinical Severity. Computers, Materials & Continua 2020; 63: 537-551
- 71 Liang W, Liang H, Ou L. et al Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAM Intern Med 2020; May 12: e202033
- 72 Yan L, Zhang HT, Goncalves J. et al An interpretable mortality prediction model for COVID-19 patients. Nature Machine Intelligence 2020; 2: 283-288
- 73 Gross O, Moerer O, Weber M. et al COVID-19-associated nephritis: early warning for disease severity and complications?. Lancet 2020; 395: 287-288